ADRs End Mixed; Adaptimmune Therapeutics, Genetic Technologies Trade Actively
08 Abril 2022 - 5:40PM
Dow Jones News
By Denny Jacob
International stocks trading in New York closed mixed on
Friday.
The S&P/BNY Mellon index of American depositary receipts
ticked down 0.1% to 155.61. The European index edged up 0.6% to
145.11. The Asian index lost 1.4% to 186.11. The Latin American
index moved up 0.7% to 227.71, while the emerging-markets index
retreated 1.1% to 320.30.
Adaptimmune Therapeutics Plc was among those whose ADRs traded
actively.
The novel cancer immunotherapy products developer fell 2.7%
after it said Friday that data from multiple solid tumor
indications confirms that MAGE-A4 is a broadly expressed cancer
target for SPEAR T-cell therapy.
Molecular diagnostics company Genetic Technologies moved down
3.8% after it provided its year to date results for the nine months
ended March 31, noting that its product geneType Multi-Risk Test
received approval for commercial release and that the U.S. Patent
and Trademark Office granted a patent for the geneType Covid-19
Risk Test.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 08, 2022 16:25 ET (20:25 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Genetic Technologies (ASX:GTG)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Genetic Technologies (ASX:GTG)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Genetic Technologies Limited da Australian Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Genetic Technologies Limited